跳至主要内容
临床试验/NCT07128316
NCT07128316进行中(未招募)不适用

Comparison of Clinical Outcomes of LASIK Using Contoura With Phorcides vs. iDesign

59th Medical Wing2 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2023年9月11日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
63
试验地点
2
主要终点
Percentage of eyes with Uncorrected Visual Acuity of 20/16 or better at 6-month Post-Op

研究概览

简要总结

Participants will undergo LASIK using Contoura with Phorcides calculation on one eye and LASIK using iDesign calculation on the contralateral eye to correct myopia.

详细描述

Once consented to participate in the study, subjects will have a comprehensive ocular examination to determine eligibility to undergo LASIK using Contoura with Phorcides calculation on one eye and LASIK using iDesign calculation on the contralateral eye to correct myopia. The study objective is to compare the 6-month visual outcomes (i.e., visual acuity, contract sensitivity, high order aberrations), quality of vision (i.e., double vision, glare, starburst, halos, etc.) and dry eye symptoms of patients undergoing contralateral LASIK using Contoura with Phorcides calculation vs. LASIK using iDesign calculation. Surgical treatment will be randomized so there is a 50% chance to receive LASIK using Contoura with Phorcides vs LASIK using iDesign calculation on the contralateral eye. Subjects will receive standard of care topical ophthalmic antibiotic and steroid drops. This will be a prospective randomized double blind contralateral study. The patient and the staff doing the post-op evaluations will be blinded to which eye received which treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

This is a prospective randomized double blind contralateral study. The patient and the staff doing the post-op evaluations will be blinded to which eye received which treatment.

入排标准

年龄范围
21 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male and Females between the ages of 21 and 50
  • Nearsightedness between -2.00 diopters and -8.00 diopters
  • Have similar levels of nearsightedness in each eye (1.5D of difference between eyes)
  • Less than or equal to 3.00 diopters of astigmatism
  • Have similar levels of astigmatism in each eye (0.75D of difference between eyes)
  • Total spherical equivalent (SE) of no more than -9.0 D
  • Tricare Prime or Tricare Select Beneficiary
  • Residing within 60 miles radius from Lackland AFB

排除标准

  • Subjects with corneal abnormal findings including signs of keratoconus, keratoconus suspect, abnormal corneal topography, epithelial basement membrane disease, pellucid marginal degeneration, corneal degenerations, progressive and unstable myopia, irregular or unstable corneal mires on central keratometry images, and patients whose corneal thickness would cause anticipated treatment would violate the posterior 250 microns of corneal stroma from the corneal endothelium.
  • Subjects with any ocular disease such as advanced/uncontrolled glaucoma, severe dry eye, active eye infection or inflammation, recent herpes eye infection or problems resulting from past infection.
  • Subjects with active collagen vascular, connective tissue, autoimmune or immunodeficiency diseases
  • Pregnant or nursing females
  • Systemic disease likely to affect wound healing, such as diabetes and severe atopy
  • Taking the medication Isotretinoin (Accutane) or antimetabolites for any medical condition

结局指标

主要结局

Percentage of eyes with Uncorrected Visual Acuity of 20/16 or better at 6-month Post-Op

时间窗: 6-month Post-Op

Post-operative uncorrected visual acuity of 20/16 or better measure with ETDRS chart; unit = percentage eyes with Uncorrected Visual Acuity.

次要结局

  • Change in high contrast visual acuity at 6-month Post-Op(Change from baseline (pre-op) to 6-month Post-Op)
  • Change in refractive error at 6-month Post-Op(Change from baseline (pre-op) to 6-month Post-Op)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验